New perspectives in coronary heart disease management

New perspectives in coronary heart disease management

The article is devoted to ACE inhibitor therapy in stable coronary heart disease (CHD). The author analyzes the results of multi-center trials on various ACE inhibitors’ efficacy in decreasing risk of all-cause mortality, fatal and non-fatal myocardial infarction, stroke, chronic heart failure in CH...

Full description

Bibliographic Details
Main Author:	V. I. Makolkin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2005-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ишемическая болезнь сердца факторы риска лечение ингибиторы ангиотензин-превращающего фермента
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/917

Similar Items

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Endothelial dysfunction in arterial hypertension - cardiovascular complication risk factor
by: B. A. Namakanov, et al.
Published: (2005-12-01)

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

Levels of cytokines and C-reactive protein as treatment effectiveness criteria in patients with coronary heart disease and chronic heart failure
by: E. Yu. Sazhina, et al.
Published: (2008-06-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

PRESTIGE study: ACE inhibitors efficacy in patients with acute myocardial infarction and left ventricular dysfunction
by: Yu. N. Belenkov, et al.
Published: (2005-04-01)

Heart diastolic dysfunction in patients with familial arterial hypertension
by: B. A. Namakanov, et al.
Published: (2005-06-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitor cilazapril: its place in cardiovascular diseases treatment
by: G. A. Baryshnikova
Published: (2005-08-01)

Coronary heart disease development in heterozygotic form of familial hypercholesterolemia
by: P. P. Malyshev, et al.
Published: (2006-10-01)

Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
by: V. I. Makolkin
Published: (2010-08-01)

Association of smoking with coronary artery disease depending on other cardiovascular risk factors
by: E. D. Bazdyrev, et al.
Published: (2021-04-01)

Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Risk factors for cardiovascular diseases and coronary artery disease among military population
by: A. E. Masimova, et al.
Published: (2021-02-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

PSYCHOSOCIAL FACTORS AND LIFE QUALITY IN CORONARY HEART DISEASE PATIENTS: RESULTS OF THE RUSSIAN PART OF INTERNATIONAL MULTICENTER STUDY EUROASPIRE IV
by: N. V. Pogosova, et al.
Published: (2017-10-01)

Inflammation role in atrial fibrillation pathogenesis
by: A. I. Tarzimanova, et al.
Published: (1970-01-01)

Perindopril arginine: a new ACE inhibitor salt increases therapeutic potential
by: Yu. A. Karpov
Published: (2008-12-01)

Own and parental predictors of tobacco smoking in children with early coronary heart disease
by: M. V. Konnov, et al.
Published: (2020-11-01)

THE INFLUENCE OF PSYCHOSOCIAL FACTORS ON THE DEVELOPMENT OF ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME
by: K. G. Kozhokar, et al.
Published: (2016-06-01)

PREVALENCE OF CARDIAC RISK FACTORS IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
by: V. S. Arakelyan, et al.
Published: (2019-06-01)

THE RELATION OF SMOKING AND ALCOHOL CONSUMPTION WITH CORONARY HEART DISEASE AND ITS RISK FACTORS (ESSE-RF IN KEMEROVSKAYA REGION)
by: S. A. Maximov, et al.
Published: (2018-06-01)

Coronary heart disease and risk factors in elderly population
by: A. E. Imaeva, et al.
Published: (2016-04-01)

Family associations of coronary heart disease risk factors in adolescents
by: D. V. Denisova, et al.
Published: (2007-02-01)

Clinical value of soluble CD40 ligand in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (1970-01-01)

Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey
by: N. V. Pogosova, et al.
Published: (2020-12-01)

ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ
Published: (2016-12-01)

ASSOCIATION BETWEEN ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY, BONE MASS, AND OSTEOPOROSIS RISK FACTORS
by: K. E. Sobchenko, et al.
Published: (2013-10-01)

Arterial hypertension and coronary heart disease in real-world cardiology practice
by: S. A. Shalnova, et al.
Published: (2006-04-01)

LIPID TRANSPORT GENETIC POLYMORPHISM AND ANGIOTENSIN-CONVERTING ENZYME I/D GENETIC POLYMORPHISM IN UZBEK PATIENTS WITH UNSTABLE ANGINA AND CORONARY HEART DISEASE IN FAMILY HISTORY
by: R. D. Kurbanov, et al.
Published: (2013-04-01)